Latest Articles

Publication Date
Sentinel lymph node distribution in endometrial cancer: clinical patterns and implications from a 292-patient cohort - Via Medica Journals

Sentinel lymph node distribution in endometrial cancer: clinical patterns and implications from a 292-patient cohort Via Medica Journals

Published: April 22, 2026, 2:34 p.m.
Opinion: Provider-patient communication is key to giving women more health care autonomy - Daily Bruin

Opinion: Provider-patient communication is key to giving women more health care autonomy Daily Bruin

Published: April 21, 2026, 6:53 p.m.
Meet a graduating nursing student inspired by personal experiences to advocate for patients - Case Western Reserve University

Meet a graduating nursing student inspired by personal experiences to advocate for patients Case Western Reserve University

Published: April 21, 2026, 11:32 a.m.
FDA Approves IMFINZI Plus Carboplatin and Paclitaxel for Certain Patients With Endometrial Cancer - EMJ

FDA Approves IMFINZI Plus Carboplatin and Paclitaxel for Certain Patients With Endometrial Cancer EMJ

Published: April 21, 2026, 3:59 a.m.
“Transforms The Way We Talk To Patients” Sparks Consent Debate In 2026 – Here’s Why - Glass Almanac

“Transforms The Way We Talk To Patients” Sparks Consent Debate In 2026 – Here’s Why Glass Almanac

Published: April 14, 2026, 4:06 p.m.
How NHS ‘medical misogyny’ is failing female patients - The Independent

How NHS ‘medical misogyny’ is failing female patients The Independent

Published: April 14, 2026, 2:47 p.m.
1:1 Peer Support Improves Treatment Completion Cancer Patients - SurvivorNet

1:1 Peer Support Improves Treatment Completion Cancer Patients SurvivorNet

Published: April 14, 2026, 1:52 a.m.
AR tech prepares patients for endometriosis surgery - AOL.com

AR tech prepares patients for endometriosis surgery AOL.com

Published: April 12, 2026, 9:16 p.m.
BioNTech and DualityBio’s Antibody-Drug Conjugate Trastuzumab Pamirtecan Demonstrated Clinically Meaningful Efficacy in Patients with HER2-Expressing, Recurrent Endometrial Cancer - The Manila Times

BioNTech and DualityBio’s Antibody-Drug Conjugate Trastuzumab Pamirtecan Demonstrated Clinically Meaningful Efficacy in Patients with HER2-Expressing, Recurrent Endometrial Cancer The Manila Times

Published: April 11, 2026, 11:01 a.m.
New Survey Data Exploring Patient Experiences with Endometrial Cancer Care Presented at 2026 Society of Gynecologic Oncology (SGO) Annual Meeting on Women's Cancer - StreetInsider

New Survey Data Exploring Patient Experiences with Endometrial Cancer Care Presented at 2026 Society of Gynecologic Oncology (SGO) Annual Meeting on Women's Cancer StreetInsider

Published: April 10, 2026, 11:01 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!